USX Cyber® Launches Guardient® for SMBs as CMMC Enforcement Begins – Helping Businesses Get Compliant Faster, More Affordably, and More Effectively 
Nissin Foods Announces 2025 Q3 Financial Results 
FurGPT Strengthens Global Presence Following Multi-Exchange Listings 
Krown Network Surpasses Ethereum & Bitcoin Pre-Launch Velocity Records; 7x ETH’s ICO Pace 
17th Hong Kong International Wine & Spirits Fair wraps up on a high note with over 8,200 buyers GreenPro Capital CEO Outlines Plans of Making CryptoSX the Leading STO Exchange Platform
KUALA LUMPUR / ACCESSWIRE / August 10, 2021 / Greenpro Capital Corp. (NASDAQ:GRNQ). CEO Dr….
Legion Capital Named on CIO Bulletin’s Top 50 Best Companies to Watch 2021
FinTech Lender excelling with growing real estate market in the United States ORLANDO, FL /…
SponsorsOne Announces Signing of the Second Largest Wine and Spirits Distributor in the USA – Republic National Distributing Company (RNDC) to Distribute Doc Wylder’s
Ready to Drink Spirits market is forecasted to be bigger than wine in the US…
Speedcast and HudsonCyber Team Up to Help Companies Regain Cyber Control
Cybersecurity assessment solution developed by leading cyber community organization helps to meet compliance and regulatory…
Levitee Labs Announces Azim Qazi as Head of Ecommerce and Consumer Packaged Goods
Azim Qazi, MBA, MCIPS, P.Log has over 20 years of management experience in supply chain…
Valneva Reports H1 2021 Financial Results and Provides Business Update
Key R&D Milestones Achieved Positive topline Phase 3 results for single-shot chikungunya vaccine candidate VLA1553…
Eliem Therapeutics Announces Pricing of Initial Public Offering
SEATTLE and CAMBRIDGE, United Kingdom, Aug. 09, 2021 (GLOBE NEWSWIRE) — Eliem Therapeutics, Inc., a…
atai Life Sciences to Host Conference Call and Webcast to Discuss Second Quarter 2021 Financial Results and Provide Business Update
BERLIN, Aug. 09, 2021 (GLOBE NEWSWIRE) — atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a…
CORRECTING and REPLACING – GoodRx and Boehringer Ingelheim Announce Joint Effort to Deliver Affordability Solutions to Patients
Potential to provide approximately $15 million a year in savings for life-enhancing medications SANTA MONICA,…
Bioasis Announces Allowance of Japanese Patent Application in Japan Relating to xB³™ Fusion Protein Comprising Iduronate-2-sulfatase
NEW HAVEN, Conn., Aug. 09, 2021 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the…
Cronos Group Inc. to Speak at the Canaccord Genuity 41st Annual Growth Conference
TORONTO, Aug. 09, 2021 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos…
Tonix Pharmaceuticals Reports Second Quarter 2021 Financial Results and Operational Highlights
Central Nervous System Pipeline Progressing with Two Phase 2 Studies (TNX-1300 and TNX-1900) and One…
Catalyst Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Corporate Update
-Q2 2021 Total Net Revenues of $36.4 Million Reflect Strong Quarter over Quarter Growth -Q2…
Monthly information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2021
Monthly information regarding the total number of voting rights and total number of shares of…
Medexus to Present at Canaccord Genuity’s 41st Annual Growth Conference
TORONTO and CHICAGO, Aug. 09, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”)…
Idera Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
EXTON, Pa., Aug. 09, 2021 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (“Idera” or the “Company”)…
IGM Biosciences Announces Second Quarter 2021 Financial Results and Provides Corporate Update
– Recommended Phase 2 Dose of IGM-2323 Expected in 2021 – – Initial Data from…
Paratek Pharmaceuticals Announces Total Revenue of $57.5 Million in the Second Quarter 2021
— NUZYRA® (omadacycline) Generated Net U.S. Sales of $14.9 Million from the Core Commercial Business, a…
Vor Reports Second Quarter 2021 Financial Results and Provides Company Update
On track to report initial VOR33 clinical data in the first half of 2022 Announced…
AnaptysBio Announces Second Quarter 2021 Financial Results and Provides Pipeline Updates
Imsidolimab GPP GEMINI-1 Phase 3 trial anticipated to initiate in Q3 2021 following recent FDA end-of-Phase…